SLC25A41
gene geneOn this page
Also known as FLJ40442MGC34725APC4
Summary
SLC25A41 (solute carrier family 25 member 41, HGNC:28533) is a protein-coding gene on chromosome 19p13.3, encoding Mitochondrial carrier protein SCaMC-3L (Q8N5S1). Calcium-independent ATP-Mg/Pi exchanger that catalyzes the electroneutral exchange of Mg-ATP or free ADP against an hydrogenphosphate and participates in the net transport of adenine nucleotides across the mitochondria inner membrane.
SLC25A41 belongs to the SLC25 family of mitochondrial carrier proteins (Haitina et al., 2006 [PubMed 16949250]).
Source: NCBI Gene 284427 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 86 total
- MANE Select transcript:
NM_173637
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28533 |
| Approved symbol | SLC25A41 |
| Name | solute carrier family 25 member 41 |
| Location | 19p13.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ40442, MGC34725, APC4 |
| Ensembl gene | ENSG00000181240 |
| Ensembl biotype | protein_coding |
| OMIM | 610822 |
| Entrez | 284427 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 2 nonsense_mediated_decay, 1 protein_coding
ENST00000321510, ENST00000458275, ENST00000597558
RefSeq mRNA: 2 — MANE Select: NM_173637
NM_001321298, NM_173637
CCDS: CCDS45937
Canonical transcript exons
ENST00000321510 — 7 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001262551 | 6432049 | 6432204 |
| ENSE00003511571 | 6429724 | 6429831 |
| ENSE00003561683 | 6430009 | 6430161 |
| ENSE00003578040 | 6427103 | 6427250 |
| ENSE00003668630 | 6426037 | 6426561 |
| ENSE00003687244 | 6427334 | 6427501 |
| ENSE00003894373 | 6433487 | 6433763 |
Expression profiles
Bgee: expression breadth ubiquitous, 147 present calls, max score 82.53.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0148 / max 20.2988, expressed in 3 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 178637 | 0.0148 | 3 |
Top tissues by expression
241 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| cerebellar hemisphere | UBERON:0002245 | 82.53 | gold quality |
| cerebellar cortex | UBERON:0002129 | 82.32 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 81.99 | gold quality |
| cerebellum | UBERON:0002037 | 80.78 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 77.47 | silver quality |
| putamen | UBERON:0001874 | 76.79 | gold quality |
| left testis | UBERON:0004533 | 76.72 | gold quality |
| right testis | UBERON:0004534 | 76.56 | gold quality |
| nucleus accumbens | UBERON:0001882 | 75.97 | gold quality |
| caudate nucleus | UBERON:0001873 | 75.85 | gold quality |
| testis | UBERON:0000473 | 73.56 | gold quality |
| right frontal lobe | UBERON:0002810 | 73.51 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 72.17 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 71.82 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 70.82 | gold quality |
| cortical plate | UBERON:0005343 | 70.18 | gold quality |
| prefrontal cortex | UBERON:0000451 | 69.96 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 69.67 | gold quality |
| neocortex | UBERON:0001950 | 68.17 | gold quality |
| amygdala | UBERON:0001876 | 67.97 | gold quality |
| frontal cortex | UBERON:0001870 | 67.90 | gold quality |
| mucosa of stomach | UBERON:0001199 | 67.87 | gold quality |
| brain | UBERON:0000955 | 66.87 | gold quality |
| cerebral cortex | UBERON:0000956 | 66.23 | gold quality |
| forebrain | UBERON:0001890 | 66.02 | gold quality |
| hypothalamus | UBERON:0001898 | 65.65 | gold quality |
| Ammon’s horn | UBERON:0001954 | 64.30 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 64.09 | gold quality |
| lower esophagus | UBERON:0013473 | 64.02 | gold quality |
| myocardium | UBERON:0002349 | 63.93 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.29 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
16 targeting SLC25A41, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4715-3P | 99.98 | 66.03 | 670 |
| HSA-MIR-545-3P | 99.95 | 70.74 | 2783 |
| HSA-MIR-6738-3P | 99.03 | 67.14 | 1326 |
| HSA-MIR-5001-3P | 98.91 | 67.28 | 1394 |
| HSA-MIR-4260 | 98.78 | 65.37 | 848 |
| HSA-MIR-1227-5P | 98.65 | 65.32 | 1549 |
| HSA-MIR-6818-5P | 97.50 | 67.10 | 1167 |
| HSA-MIR-1289 | 97.46 | 65.37 | 655 |
| HSA-MIR-4640-5P | 97.42 | 66.33 | 1543 |
| HSA-MIR-4726-5P | 97.24 | 65.67 | 1299 |
| HSA-MIR-4750-3P | 96.65 | 64.38 | 512 |
| HSA-MIR-6762-5P | 96.55 | 64.62 | 972 |
| HSA-MIR-6845-5P | 96.55 | 64.65 | 969 |
| HSA-MIR-3135A | 96.41 | 65.30 | 494 |
| HSA-MIR-2861 | 95.24 | 65.47 | 1056 |
| HSA-MIR-6726-3P | 83.39 | 62.13 | 46 |
Literature-anchored findings (GeneRIF, showing 2)
- Compares and contrasts all the known human SLC25A* genes and includes functional information. (PMID:23266187)
- The APC4 subunit is the major SUMO target in the anaphase-promoting complex/cyclosome, containing SUMO acceptor lysines at positions 772 and 798. (PMID:29549242)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Slc25a41 | ENSMUSG00000011486 |
| rattus_norvegicus | Slc25a41 | ENSRNOG00000048853 |
Paralogs (49): SLC25A13 (ENSG00000004864), SLC25A5 (ENSG00000005022), SLC25A39 (ENSG00000013306), SLC25A40 (ENSG00000075303), SLC25A3 (ENSG00000075415), SLC25A43 (ENSG00000077713), SLC25A24 (ENSG00000085491), SLC25A1 (ENSG00000100075), SLC25A17 (ENSG00000100372), SLC25A14 (ENSG00000102078), SLC25A15 (ENSG00000102743), SLC25A11 (ENSG00000108528), UCP1 (ENSG00000109424), SLC25A36 (ENSG00000114120), SLC25A12 (ENSG00000115840), SLC25A2 (ENSG00000120329), SLC25A51 (ENSG00000122696), SLC25A16 (ENSG00000122912), SLC25A35 (ENSG00000125434), SLC25A19 (ENSG00000125454), SLC25A23 (ENSG00000125648), SLC25A47 (ENSG00000140107), SLC25A52 (ENSG00000141437), SLC25A38 (ENSG00000144659), SLC25A26 (ENSG00000144741), SLC25A48 (ENSG00000145832), SLC25A37 (ENSG00000147454), SLC25A25 (ENSG00000148339), SLC25A31 (ENSG00000151475), SLC25A4 (ENSG00000151729), SLC25A27 (ENSG00000153291), SLC25A28 (ENSG00000155287), SLC25A44 (ENSG00000160785), SLC25A45 (ENSG00000162241), SLC25A34 (ENSG00000162461), SLC25A32 (ENSG00000164933), SLC25A6 (ENSG00000169100), SLC25A33 (ENSG00000171612), SLC25A30 (ENSG00000174032), UCP3 (ENSG00000175564)
Protein
Protein identifiers
Mitochondrial carrier protein SCaMC-3L — Q8N5S1 (reviewed: Q8N5S1)
Alternative names: Mitochondrial ATP-Mg/Pi carrier protein SLC25A41, Small calcium-binding mitochondrial carrier protein 3-like, Solute carrier family 25 member 41
All UniProt accessions (1): Q8N5S1
UniProt curated annotations — full annotation on UniProt →
Function. Calcium-independent ATP-Mg/Pi exchanger that catalyzes the electroneutral exchange of Mg-ATP or free ADP against an hydrogenphosphate and participates in the net transport of adenine nucleotides across the mitochondria inner membrane.
Subcellular location. Mitochondrion inner membrane.
Miscellaneous. May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay.
Similarity. Belongs to the mitochondrial carrier (TC 2.A.29) family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8N5S1-1 | 1 | yes |
| Q8N5S1-2 | 2 |
RefSeq proteins (2): NP_001308227, NP_775908* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002067 | MCP | Family |
| IPR018108 | MCP_transmembrane | Repeat |
| IPR023395 | MCP_dom_sf | Homologous_superfamily |
Pfam: PF00153
Catalyzed reactions (Rhea), 2 shown:
- Mg(2+)(out) + phosphate(in) + ATP(out) = Mg(2+)(in) + phosphate(out) + ATP(in) (RHEA:65840)
- ADP(out) + phosphate(in) + H(+)(out) = ADP(in) + phosphate(out) + H(+)(in) (RHEA:65844)
UniProt features (14 total): transmembrane region 6, repeat 3, splice variant 2, sequence variant 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8N5S1-F1 | 73.09 | 0.21 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 46 (showing top):
GCANCTGNY_MYOD_Q6, CAGCTG_AP4_Q5, GOBP_NUCLEOTIDE_TRANSPORT, GOBP_ORGANOPHOSPHATE_ESTER_TRANSPORT, GOMF_NUCLEOBASE_CONTAINING_COMPOUND_TRANSMEMBRANE_TRANSPORTER_ACTIVITY, GOBP_NUCLEOTIDE_TRANSMEMBRANE_TRANSPORT, GOBP_NUCLEOBASE_CONTAINING_COMPOUND_TRANSPORT, GOBP_ORGANIC_ANION_TRANSPORT, GOCC_MITOCHONDRIAL_ENVELOPE, GOBP_PURINE_NUCLEOTIDE_TRANSPORT, GOBP_CARBOHYDRATE_DERIVATIVE_TRANSPORT, GOBP_TRANSMEMBRANE_TRANSPORT, GOCC_ORGANELLE_INNER_MEMBRANE, chr19p13, GOMF_ORGANOPHOSPHATE_ESTER_TRANSMEMBRANE_TRANSPORTER_ACTIVITY
GO Biological Process (5): ADP transport (GO:0015866), ATP transport (GO:0015867), mitochondrial ADP transmembrane transport (GO:0140021), mitochondrial ATP transmembrane transport (GO:1990544), transmembrane transport (GO:0055085)
GO Molecular Function (2): ATP transmembrane transporter activity (GO:0005347), ADP transmembrane transporter activity (GO:0015217)
GO Cellular Component (3): mitochondrion (GO:0005739), mitochondrial inner membrane (GO:0005743), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| purine ribonucleotide transport | 2 |
| adenine nucleotide transport | 2 |
| ADP transport | 2 |
| purine-containing compound transmembrane transport | 2 |
| nucleotide transmembrane transport | 2 |
| ATP transport | 2 |
| adenine nucleotide transmembrane transporter activity | 2 |
| purine ribonucleotide transmembrane transporter activity | 2 |
| transport | 1 |
| cellular process | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
| organelle inner membrane | 1 |
| mitochondrial membrane | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
958 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SLC25A41 | TMEM210 | A6NLX4 | 626 |
| SLC25A41 | SMIM9 | A6NGZ8 | 607 |
| SLC25A41 | SLC25A35 | Q3KQZ1 | 498 |
| SLC25A41 | PRR22 | Q8IZ63 | 478 |
| SLC25A41 | SMIM8 | Q96KF7 | 451 |
| SLC25A41 | CTIF | O43310 | 419 |
| SLC25A41 | TDRD6 | O60522 | 392 |
| SLC25A41 | TOMM20L | Q6UXN7 | 383 |
| SLC25A41 | SRP68 | Q9UHB9 | 357 |
| SLC25A41 | F6RGN5 | F6RGN5 | 352 |
| SLC25A41 | CBY2 | Q8NA61 | 334 |
| SLC25A41 | DPM3 | Q9P2X0 | 332 |
| SLC25A41 | TMEM98 | Q9Y2Y6 | 332 |
| SLC25A41 | DENND1C | Q8IV53 | 330 |
| SLC25A41 | SLC25A52 | Q3SY17 | 328 |
IntAct
4 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SLC25A41 | NUDT19 | psi-mi:“MI:0914”(association) | 0.530 |
| SLC25A41 | VPS37C | psi-mi:“MI:0914”(association) | 0.350 |
| SLC25A41 | TMOD1 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (196): HSPD1 (Affinity Capture-MS), AP2M1 (Affinity Capture-MS), SPECC1L (Affinity Capture-MS), SPECC1 (Affinity Capture-MS), PALM (Affinity Capture-MS), RP2 (Affinity Capture-MS), STXBP2 (Affinity Capture-MS), BMP2K (Affinity Capture-MS), EPS15 (Affinity Capture-MS), RALBP1 (Affinity Capture-MS), MFAP1 (Affinity Capture-MS), MPP7 (Affinity Capture-MS), RPRD1B (Affinity Capture-MS), TMOD2 (Affinity Capture-MS), AP2A1 (Affinity Capture-MS)
ESM2 similar proteins: A2A3V2, A3LVX1, A5DIS9, A5DX39, A6ZV78, A7A285, A7TDX5, B0G159, B3LUQ6, B4F8I5, B5VI70, F4HW79, F4JU70, K7VYZ9, O13660, O94344, O94370, P15798, P39953, P40464, P40556, P43617, P53257, Q0II44, Q19529, Q20799, Q27151, Q3MHI3, Q54VX4, Q5H9E4, Q5U3V7, Q628Z2, Q6C107, Q6CQR3, Q6DHS9, Q6FTE5, Q6ZT89, Q75EP3, Q84UC7, Q86I81
Diamond homologs: A0JN87, A1DI57, A2A3V2, A2CEQ0, A5PJZ1, B8ZHC9, F1R4U0, G3Y1Q5, O04619, O18757, O60029, O97470, P16260, P16261, P29518, P32089, P53007, P79110, Q01356, Q01888, Q08DK7, Q0CEN9, Q0II44, Q0V7M4, Q10248, Q12251, Q12482, Q2UCW8, Q3SZK0, Q4X022, Q54MZ4, Q5HZE0, Q5RFB7, Q5U3V7, Q5XHA0, Q6NYZ6, Q6PGY3, Q7T0U6, Q7ZY36, Q8BMD8
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
86 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 79 |
| Likely benign | 4 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
734 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:6427115:T:TA | donor_gain | 1.0000 |
| 19:6427328:CCATA:C | donor_loss | 1.0000 |
| 19:6427329:CATA:C | donor_loss | 1.0000 |
| 19:6427331:TACC:T | donor_loss | 1.0000 |
| 19:6427332:A:AC | donor_gain | 1.0000 |
| 19:6427333:C:CC | donor_gain | 1.0000 |
| 19:6427333:CCT:C | donor_gain | 1.0000 |
| 19:6427499:CAC:C | acceptor_gain | 1.0000 |
| 19:6427501:CCTG:C | acceptor_loss | 1.0000 |
| 19:6427502:C:CC | acceptor_gain | 1.0000 |
| 19:6427502:C:CG | acceptor_loss | 1.0000 |
| 19:6427503:T:C | acceptor_loss | 1.0000 |
| 19:6427508:A:AC | acceptor_gain | 1.0000 |
| 19:6427508:A:C | acceptor_gain | 1.0000 |
| 19:6427512:C:CT | acceptor_gain | 1.0000 |
| 19:6427513:G:T | acceptor_gain | 1.0000 |
| 19:6429718:TCTTA:T | donor_loss | 1.0000 |
| 19:6429720:TTA:T | donor_loss | 1.0000 |
| 19:6429721:T:TA | donor_loss | 1.0000 |
| 19:6429827:TTGCA:T | acceptor_gain | 1.0000 |
| 19:6429828:TGCA:T | acceptor_gain | 1.0000 |
| 19:6429829:GCA:G | acceptor_gain | 1.0000 |
| 19:6429830:CA:C | acceptor_gain | 1.0000 |
| 19:6429830:CAC:C | acceptor_gain | 1.0000 |
| 19:6429832:C:CC | acceptor_gain | 1.0000 |
| 19:6430038:A:AC | donor_gain | 1.0000 |
| 19:6430039:C:CC | donor_gain | 1.0000 |
| 19:6430042:AGGAG:A | donor_gain | 1.0000 |
| 19:6430043:G:C | donor_gain | 1.0000 |
| 19:6426562:C:CC | acceptor_gain | 0.9900 |
AlphaMissense
2375 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:6430046:G:T | A160D | 0.992 |
| 19:6430024:G:C | F167L | 0.991 |
| 19:6430024:G:T | F167L | 0.991 |
| 19:6430026:A:G | F167L | 0.991 |
| 19:6430034:G:T | A164D | 0.986 |
| 19:6427493:C:A | K211N | 0.985 |
| 19:6427493:C:G | K211N | 0.985 |
| 19:6430043:G:T | P161H | 0.985 |
| 19:6427143:G:C | S300R | 0.984 |
| 19:6427143:G:T | S300R | 0.984 |
| 19:6427145:T:G | S300R | 0.984 |
| 19:6427396:C:G | G244R | 0.984 |
| 19:6427156:C:T | G296D | 0.982 |
| 19:6430069:G:C | N152K | 0.982 |
| 19:6430069:G:T | N152K | 0.982 |
| 19:6429761:G:T | A196D | 0.981 |
| 19:6430051:C:A | K158N | 0.981 |
| 19:6430051:C:G | K158N | 0.981 |
| 19:6426455:C:A | K349N | 0.980 |
| 19:6426455:C:G | K349N | 0.980 |
| 19:6427123:C:G | R307P | 0.980 |
| 19:6430080:A:G | W149R | 0.979 |
| 19:6430080:A:T | W149R | 0.979 |
| 19:6430027:C:A | K166N | 0.977 |
| 19:6430027:C:G | K166N | 0.977 |
| 19:6430035:C:G | A164P | 0.976 |
| 19:6432092:C:G | R107P | 0.976 |
| 19:6427160:A:G | C295R | 0.975 |
| 19:6430074:C:G | G151R | 0.975 |
| 19:6427395:C:T | G244D | 0.974 |
dbSNP variants (sampled 300 via entrez): RS1000362447 (19:6425573 C>A,G), RS1000422722 (19:6432000 C>T), RS1000444622 (19:6436756 C>T), RS1000699920 (19:6436442 G>T), RS1000758584 (19:6431398 G>A), RS1000800364 (19:6425743 C>A,T), RS1000932963 (19:6435966 A>G), RS1001110991 (19:6425729 C>A,T), RS1001330994 (19:6428144 C>A,T), RS1001858023 (19:6428220 C>A,T), RS1001888150 (19:6434574 A>G), RS1001940309 (19:6434851 G>C), RS1002336929 (19:6437902 T>TA), RS1002381580 (19:6426897 C>G), RS1002490017 (19:6434479 C>G)
Disease associations
OMIM: gene MIM:610822 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: transporter — Mitochondrial nucleotide transporter subfamily
CTD chemical–gene interactions
12 total (human), top 12 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | increases methylation, decreases expression | 2 |
| propionaldehyde | increases expression | 1 |
| bisphenol A | affects cotreatment, decreases methylation | 1 |
| mono-(2-ethylhexyl)phthalate | decreases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Fulvestrant | affects cotreatment, decreases methylation | 1 |
| Acetaminophen | increases expression | 1 |
| Cadmium | decreases expression, increases abundance | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Cadmium Chloride | decreases expression, increases abundance | 1 |
| Copper Sulfate | decreases expression | 1 |
| Acrylamide | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.